Drugs / SID530
last change Jan 2011 re-read 3 minutes ago

SID530

Developed for
non-small cell lung carcinoma
Investigated by
SK Chemicals Co., Ltd.

Trials 1

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00931008 Oct 2009 → Jan 2011 non-small cell lung carcinoma SK Chemicals Co., Ltd. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SID530 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00931008 ↗